News

Gilead Sciences Is Closing In on an All-Time High. The Case for More Upside.
Gilead Sciences delivered a breakout performance Friday, surging 8.3% to $119.41 in its strongest single-day gain in nearly ...
Wall Street clocks another winning week
Wall Street and the Fed will get more insight next week on inflation’s temperature and the economy. The government will ...
Asian shares advance ahead of Trump’s deadline for imposing higher tariffs on Chinese goods
Shares advanced in Asia on Monday, a day ahead of U.S. President Donald Trump’s deadline for imposing higher tariffs on goods ...
Gilead Sciences (GILD) Touches New Record High as 10 Analysts Turn Bullish
We recently published 10 Stocks with Eye-Popping Gains; 5 Jump to New Highs. Gilead Sciences, Inc. (NASDAQ:GILD) is one of ...
Precision Medicine Online2d
Gilead's Optimistic Relaxed CAR T Safety Monitoring Could Help Sluggish Yescarta, Tecartus Q2 Sales
Even though oncology segment revenue inched up just 1 percent year over year, the firm lifted full-year expectations slightly ...
Gilead Sciences shares soar; analysts lift targets on HIV strength and Yeztugo outlook
Analysts lift targets for Gilead as HIV sales surge and Yeztugo launch gains traction, supporting a stronger full-year ...
Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears
Gilead Sciences (NASDAQ:GILD) announced its second-quarter 2025 earnings and revised annual outlook after the market closed ...
Gilead Sciences jumps after Q2 beat; Truist upgrades to Buy
Gilead Sciences ( NASDAQ: GILD) was upgraded to Buy from Hold at Truist after the company raised full year sales and profit ...
Gilead Sciences Up Over 8%, on Track for Highest Close Since June 2015 — Data Talk
Gilead Sciences Up Over 8%, on Track for Highest Close Since June 2015 — Data Talk Gilead Sciences, Inc. (GILD) is currently at $119.75, up $9.47 or 8.59% --Would be highest close since June 25, 2015, ...